I've been saying this.
We will need a footprint in the US for the FDA to be comfortable, imo. We know this is already in the works from the previous 10k's.
This is what I believe is needed before FDA submission:
1.) MHRA Approval
2.) US Based Contract Manufacturing
3.) Flaskworks Approval (added bonus)
Also, the logistics and planning for our eventual ramp-up of DCVax to the public will take time, money and will come with several lessons learned; it won't be instant and it won't be easy. The UK is the best place to start and learn.
Once we have that set in stone, an eventual rollout in the US will be much easier.